Citichem India

Who are the top shareholders of the Citichem India?

The top shareholder of Citichem India is Arif Esmail Merchant, holding 27.83%, with no pledged promoter holdings. Globopac India Private Limited is the largest public shareholder at 4.41%, while individual investors own 30.64% of the company.

The top shareholders of Citichem India include the promoters, with Arif Esmail Merchant holding the largest share at 27.83%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) involved. The highest public shareholder is Globopac India Private Limited, which holds 4.41%. Additionally, individual investors collectively own 30.64% of the company.

What does Citichem India do?

Citichem India Ltd, a micro-cap company established in 1992, operates in the miscellaneous industry and reported net sales of 1 Cr and no net profit for June 2024, with a market cap of Rs 19 Cr. Key metrics include a P/E ratio of 15.00 and a debt-equity ratio of 0.07.

Overview:<BR>Citichem India Ltd operates in the miscellaneous industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Citichem India Limited was incorporated in 1992 as Citichem Alkalies (Bombay) Private Limited. It later converted to a public limited company and changed its name to Citichem Alkalies (Bombay) Limited in 1999. The latest quarterly results reported net sales and net profit for June 2024.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1 Cr (Quarterly Results - Jun 2024) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Jun 2024) <BR>Market-cap value: Rs 19 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 15.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.07 <BR>Return on Equity: 16.96% <BR>Price to Book: 2.57 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Has Citichem India declared dividend?

No Dividend History Available

Who are the peers of the Citichem India?

Citichem India's peers include Glittek Granites, Laffans Petroch, Shiva Granito, Jai Mata Glass, and others. Citichem India has excellent growth and average capital structure, while peers show varied management risks and returns, with Glittek Granites having the highest 1-year return at 153.99%.

Peers: The peers of Citichem India are Glittek Granites, Laffans Petroch, Shiva Granito, Jai Mata Glass, Solid Stone Co, Triveni Glass, Marinetrans Indi, Antarctica, Veritaas Adver, and Madhya Prad. Tod.<BR><BR>Quality Snapshot: Excellent management risk is observed at Veritaas Adver., while Average management risk is found at Marinetrans Indi. Below Average management risk is noted for Glittek Granites, Laffans Petroch, Shiva Granito, Solid Stone Co, and Antarctica, and the rest. Citichem India has an Excellent growth rating, while Below Average growth is seen in Glittek Granites, Laffans Petroch, Shiva Granito, Solid Stone Co, and the rest. Jai Mata Glass and Triveni Glass do not qualify for growth. Citichem India has an Average capital structure, while Below Average capital structure is found at Glittek Granites, Laffans Petroch, Shiva Granito, Solid Stone Co, Antarctica, and the rest, with Jai Mata Glass and Triveni Glass not qualifying.<BR><BR>Return Snapshot: Glittek Granites has the highest 1-year return at 153.99%, while Laffans Petroch has the lowest at -20.89%. Citichem India's 1-year return is not available for comparison. Additionally, peers such as Laffans Petroch, Shiva Granito, Jai Mata Glass, Solid Stone Co, Triveni Glass, and Antarctica have negative six-month returns.

How big is Citichem India?

As of 24th July, Citichem India Ltd has a market capitalization of 18.00 Cr, with recent net sales of 1.10 Cr and a net profit of 0.20 Cr for the quarter ending June 2024. Shareholder's funds were 7.25 Cr, and total assets were valued at 69.33 Cr as of March 2024.

As of 24th July, Citichem India Ltd has a market capitalization of 18.00 Cr and is classified as a Micro Cap company.<BR><BR>In the latest quarter ending June 2024, Citichem India reported Net Sales of 1.10 Cr and a Net Profit of 0.20 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, where Shareholder's Funds amounted to 7.25 Cr and Total Assets were valued at 69.33 Cr.

When is the next results date for Citichem India?

The next results date for Citichem India is 14 November 2025.

The next results date for Citichem India is scheduled for 14 November 2025.

How has been the historical performance of Citichem India?

Citichem India's historical performance over the past three fiscal years shows fluctuating net sales and profitability, with net sales declining to 18.70 crore in March 2025, but a significant increase in operating income to 54.38 crore. Despite challenges, the company maintained a stable asset base of 69.92 crore and improved operating profit to 1.98 crore.

Answer:<BR>The historical performance of Citichem India shows a mixed trend over the past three fiscal years, with fluctuations in net sales, operating income, and profitability.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Citichem India reported net sales of 18.70 crore, a decline from 19.61 crore in March 2024 and 20.94 crore in March 2023. However, the company saw a significant increase in other operating income, rising to 35.68 crore in March 2025 from zero in the previous two years, leading to a total operating income of 54.38 crore, up from 19.61 crore in March 2024 and 20.94 crore in March 2023. Total expenditure also increased to 52.76 crore in March 2025, compared to 17.81 crore in March 2024 and 20.36 crore in March 2023. Operating profit (PBDIT) was reported at 1.98 crore for March 2025, slightly up from 1.80 crore in March 2024 and significantly higher than 0.58 crore in March 2023. Profit before tax was 1.66 crore in March 2025, down from 1.71 crore in March 2024, while profit after tax was 1.23 crore, a decrease from 1.39 crore in March 2024 but an increase from 0.36 crore in March 2023. The company's total assets stood at 69.92 crore in March 2025, a slight increase from 69.33 crore in March 2024, while total liabilities were 69.92 crore, indicating a stable financial position. Cash flow from operating activities was negative at -11.00 crore in March 2025, contrasting with a net cash inflow of 3.00 crore for the same period, reflecting a reliance on financing activities for liquidity. Overall, while Citichem India has experienced challenges in sales and profitability, it has managed to enhance its operating income and maintain a stable asset base.

Is Citichem India overvalued or undervalued?

As of November 17, 2025, Citichem India is fairly valued with a PE ratio of 14.93, lower than its expensive peers, and has underperformed the Sensex recently, indicating a reasonable stock price relative to its earnings and book value.

As of 17 November 2025, Citichem India has moved from a very attractive to a fair valuation grade. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 14.93, an EV to EBITDA of 15.43, and a Price to Book Value of 0.88, which suggest that the stock is reasonably priced relative to its earnings and book value.<BR><BR>In comparison to its peers, Citichem India stands out with a PE ratio lower than that of Solar Industries at 95.31 and Gujarat Fluoroch at 57.85, both of which are considered very expensive. Additionally, Godrej Industries, which is rated attractive, has a PE ratio of 37.63, indicating that Citichem India may offer a more favorable valuation in the current market. Recent stock performance has lagged behind the Sensex, with a 1-month return of -0.52%, contrasting with the Sensex's 1.19% gain, further emphasizing the fair valuation of Citichem India.

Why is Citichem India Ltd falling/rising?

As of 18-Apr, Citichem India Ltd's stock price is at 16.20, reflecting a 1.82% decline. The stock has significantly underperformed the market, with a year-to-date drop of 30.77% compared to the Sensex's 7.89% decline.

As of 18-Apr, Citichem India Ltd's stock price is falling, currently at 16.20, which reflects a decrease of 0.3 or 1.82%. This decline is evident in the stock's performance over the past week, where it has underperformed significantly with a drop of 5.15%, while the benchmark Sensex has gained 1.22%. <BR><BR>Looking at the broader context, the stock has experienced a substantial year-to-date decline of 30.77%, compared to a 7.89% drop in the Sensex, indicating a significant lag behind the market. Over the past year, Citichem India Ltd has fallen by 42.70%, while the Sensex has remained relatively stable with only a slight decrease of 0.08%. <BR><BR>Additionally, today's trading performance shows that the stock has underperformed its sector by 2.71%. Although there has been a rise in investor participation, with delivery volume increasing by 66.67% against the 5-day average, the stock's moving averages indicate a mixed picture; it is higher than the 5-day and 20-day moving averages but lower than the longer-term 50-day, 100-day, and 200-day moving averages. This suggests that while there may be some short-term interest, the overall trend remains negative, contributing to the stock's current decline.

Which are the latest news on Citichem India?